Specialist Company Strives to Improve Patient Selection and Treatment Outcomes.
Elara Pharmaceuticals Ltd exhaustively mines and analyzes multiparametric data (biochemical, genomic, proteomic, genetic, metabolic, imaging, clinical, etc.) to identify patient responders and reduce clinical and drug development risks. The process generates actionable information using fewer biomarker signatures than traditional data-mining methods, improving both efficiency and efficacy.
Read our full GEN corporate profile online (Jan 15, 2014, Vol. 34, No. 2.)